Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AAMNASDAQ:CFFSNYSE:GMRENASDAQ:MBAV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAMAA Mission Acquisition$10.41+0.1%$10.34$9.96▼$10.79$457.26MN/A67,491 shs126,162 shsCFFSCF Acquisition Corp. VII$11.28$11.28$10.95▼$11.64$115.96MN/A49,275 shsN/AGMREGlobal Medical REIT$6.28-0.1%$6.94$6.06▼$10.46$420.62M1.14473,425 shs638,784 shsMBAVM3-Brigade Acquisition V$12.40+1.4%$10.81$9.97▼$12.46$445.63MN/A206,634 shs281,781 shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAMAA Mission Acquisition+0.10%0.00%+0.58%+1.66%+1,040,999,900.00%CFFSCF Acquisition Corp. VII0.00%0.00%0.00%0.00%+2.83%GMREGlobal Medical REIT-0.16%-0.41%-8.06%-28.31%-30.33%MBAVM3-Brigade Acquisition V+1.39%+2.06%+19.00%+21.45%+1,239,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAAMAA Mission AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACFFSCF Acquisition Corp. VIIN/AN/AN/AN/AN/AN/AN/AN/AGMREGlobal Medical REIT4.3726 of 5 stars3.33.02.53.62.20.81.3MBAVM3-Brigade Acquisition VN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAMAA Mission Acquisition 0.00N/AN/AN/ACFFSCF Acquisition Corp. VII 0.00N/AN/AN/AGMREGlobal Medical REIT 2.50Moderate Buy$10.4466.10% UpsideMBAVM3-Brigade Acquisition V 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CFFS, AAM, MBAV, and GMRE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025GMREGlobal Medical REITRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$10.00 ➝ $9.004/3/2025GMREGlobal Medical REITB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$9.004/2/2025GMREGlobal Medical REITB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAMAA Mission AcquisitionN/AN/AN/AN/AN/AN/ACFFSCF Acquisition Corp. VIIN/AN/AN/AN/AN/AN/AGMREGlobal Medical REIT$137.94M3.05$0.94 per share6.72$8.10 per share0.78MBAVM3-Brigade Acquisition VN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAMAA Mission AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACFFSCF Acquisition Corp. VIIN/AN/A0.00∞N/AN/AN/AN/AN/AGMREGlobal Medical REIT$20.61M$0.03N/A7.481.433.23%0.86%0.35%8/5/2025 (Estimated)MBAVM3-Brigade Acquisition VN/AN/A0.00∞N/AN/AN/AN/AN/ALatest CFFS, AAM, MBAV, and GMRE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025GMREGlobal Medical REIT$0.22$0.22N/A$0.22$35.49 million$34.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAAMAA Mission AcquisitionN/AN/AN/AN/AN/ACFFSCF Acquisition Corp. VIIN/AN/AN/AN/AN/AGMREGlobal Medical REIT$0.609.55%N/A2,000.00%N/AMBAVM3-Brigade Acquisition VN/AN/AN/AN/AN/ALatest CFFS, AAM, MBAV, and GMRE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/28/2025GMREGlobal Medical REITquarterly$0.159.47%6/20/20257/9/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAMAA Mission AcquisitionN/AN/AN/ACFFSCF Acquisition Corp. VIIN/AN/AN/AGMREGlobal Medical REIT1.260.280.28MBAVM3-Brigade Acquisition VN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAMAA Mission AcquisitionN/ACFFSCF Acquisition Corp. VII75.96%GMREGlobal Medical REIT57.52%MBAVM3-Brigade Acquisition VN/AInsider OwnershipCompanyInsider OwnershipAAMAA Mission AcquisitionN/ACFFSCF Acquisition Corp. VII25.90%GMREGlobal Medical REIT8.50%MBAVM3-Brigade Acquisition VN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAMAA Mission AcquisitionN/A43.97 millionN/AN/ACFFSCF Acquisition Corp. VII310.28 million7.62 millionNot OptionableGMREGlobal Medical REIT3066.87 million61.33 millionOptionableMBAVM3-Brigade Acquisition VN/A35.94 millionN/AN/ACFFS, AAM, MBAV, and GMRE HeadlinesRecent News About These CompaniesM3-Brigade Acquisition V (NASDAQ:MBAV) Upgraded to "Hold" at Wall Street ZenJune 15 at 3:59 AM | americanbankingnews.comM3-Brigade Acquisition V (NASDAQ:MBAV) Stock Rating Upgraded by Wall Street ZenJune 14 at 2:16 AM | marketbeat.comMillennium Management LLC Acquires Shares of 100,000 M3-Brigade Acquisition V Corp. (NASDAQ:MBAV)June 6, 2025 | marketbeat.com166,059 Shares in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) Purchased by Toronto Dominion BankJune 1, 2025 | marketbeat.comM3-Brigade Acquisition V Corp. Appoints New CEOMay 27, 2025 | tipranks.comPolar Asset Management Partners Inc. Invests $18.86 Million in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV)May 27, 2025 | marketbeat.comToronto Dominion Bank Purchases New Position in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV)May 26, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCFFS, AAM, MBAV, and GMRE Company DescriptionsAA Mission Acquisition NYSE:AAM$10.41 +0.01 (+0.10%) As of 06/16/2025 11:26 AM EasternAA Mission Acquisition Corp. engages in the acquisition and merge of companies. It was founded on February 9, 2024 and is headquartered in The Woodlands, TX.CF Acquisition Corp. VII NASDAQ:CFFS$11.28 0.00 (0.00%) As of 05/29/2025CF Acquisition Corp. VII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the financial services, healthcare, real estate services, technology, and software industries. The company was incorporated in 2020 and is based in New York, New York.Global Medical REIT NYSE:GMRE$6.28 -0.01 (-0.10%) Closing price 06/16/2025 03:59 PM EasternExtended Trading$6.26 -0.03 (-0.46%) As of 04:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.M3-Brigade Acquisition V NASDAQ:MBAV$12.40 +0.17 (+1.39%) As of 06/16/2025 04:00 PM EasternM3-Brigade Acquisition V Corp. is a blank check company. It formed for the purpose of effecting a merger, consolidation, capital stock exchange, share exchange, asset acquisition, share purchase, stock purchase, reorganization or similar business combination with one or more businesses. M3-Brigade Acquisition V Corp. is based in NEW YORK. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
